FundComb

Investment and M&A transaction comps

Healthcare Investment & M&A Transaction Comps

Healthcare services, healthcare IT, medtech, diagnostics, life sciences tools and related healthcare transactions. Pure biotech rows are tracked separately where normal revenue multiples are less meaningful.

Consumer CPG Beauty Supplements Food & Beverage Software Healthcare Biotech
38
Reviewed transactions
11
With price data
5.1x
Median EV or valuation / revenue
13.1x
Median EV or valuation / EBITDA
Year Transactions Priced Median EV or valuation / revenue Median EV or valuation / EBITDA
2026 17 4 - -

Sortable transaction comps

Healthcare transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

5 / 12

Acquisition EV, USD

USD 19B

Investment EV, USD

-

Median EV / revenue

4.4x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

12 shown of 12 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.

Select for comparison
2026-07-31 Lallemand Inc. Undisclosed - -
HealthcareDietary Supplements
+4
EnzymesHealth IngredientsMicrobial IngredientsProbiotics
2026-07-27 American Industrial Partners Undisclosed - -
HealthcareMedtech
+1
Medical Devices
2026-04-20 Eli Lilly and Company Undisclosed - -
BiotechCAR T
+2
Cell TherapyTherapeutics
2026-04-13 Stryker 835 - -
HealthcareMedtech
+2
Medical DevicesVascular Devices
2021-10-11 Pacira BioSciences Undisclosed - 11.0x
Life SciencesConsumer
+2
Joint Pain TherapiesNon Opioid Pain Therapeutics
2020-08-31 Sociétés des Produits Nestlé S.A. / Nestlé Health Science 2,600 - -
BiotechBiopharmaceuticals
+3
Food Allergy TherapeuticsPeanut Allergy TherapyTherapeutics
VCA Inc.
Control (100%)
 2017-01-09 Mars, Incorporated 9,100 3.6x -
HealthcareConsumer
+2
PetVeterinary Healthcare Services
Capsugel S.A.
Control (100%)
 2016-12-15 Lonza Group 5,500 5.1x 15.1x
HealthcareDrug Delivery Technologies
+3
Hard CapsulesOral Dosage DeliveryPharmaceutical Manufacturing Technologies
- Viome Undisclosed - -
HealthcareHealthcare Services
+3
Clinic NetworkTherapeutic Plasma ExchangeTherapeutic Plasma Exchange Services
Celgene
Control
 - Bristol-Myers Squibb Undisclosed - -
BiotechLife Sciences
+2
PharmaTherapeutics
- GE HealthCare 945 - -
DiagnosticsHealthcare
+4
MedtechContract ManufacturingRadiopharmaceutical ManufacturingRadiopharmaceuticals
Vyne Medical
Control
 - MRO Undisclosed - -
HealthcareClinical Data Management
+3
Document WorkflowHealth Information ExchangeHealthcare Software
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.